Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Kullak-Ublick, Gerd A; Andrade, Raul J; Merz, Michael; End, Peter; Benesic, Andreas; Gerbes, Alexander L; Aithal, Guruprasad P (2017). Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut, 66(6):1154-1164.

Peta, Valentina; Tse, Chantal; Perazzo, Hugo; Munteanu, Mona; Ngo, Yen; Ngo, An; Ramanujam, Nittia; Verglas, Lea; Mallet, Maxime; Ratziu, Vlad; Thabut, Dominique; Rudler, Marika; Thibault, Vincent; Schuppe-Koistinen, Ina; Bonnefont-Rousselot, Dominique; Hainque, Bernard; Imbert-Bismut, Fran├žoise; Merz, Michael; Kullak-Ublick, Gerd; Andrade, Raul; van Boemmel, Florian; Schott, Eckart; Poynard, Thierry (2017). Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery. PLoS ONE, 12(12):e0189436.

Schadt, Heiko S; Wolf, Armin; Pognan, Francois; Chibout, Salah-Dine; Merz, Michael; Kullak-Ublick, Gerd A (2016). Bile acids in drug induced liver injury: Key players and surrogate markers. Clinics and Research in Hepatology and Gastroenterology, 40(3):257-266.

Visentin, Michele; Stieger, Bruno; Merz, Michael; Kullak-Ublick, Gerd A (2015). Octreotide Inhibits the Bilirubin Carriers Organic Anion Transporting Polypeptides 1B1 and 1B3 and the Multidrug Resistance-Associated Protein 2. Journal of Pharmacology and Experimental Therapeutics, 355(2):145-151.

Weiler, Stefan; Merz, Michael; Kullak-Ublick, Gerd A (2015). Drug-induced liver injury: the dawn of biomarkers? F1000 Prime Reports, 7(34):online.

Kullak-Ublick, Gerd A; Merz, Michael; Griffel, Louis; Kaplowitz, Neil; Watkins, Paul B (2014). Liver safety assessment in special populations (hepatitis B, C, and oncology trials). Drug Safety, 37 Suppl:57-62.

Merz, Michael; Lee, Kwan R; Kullak-Ublick, Gerd A; Brueckner, Andreas; Watkins, Paul B (2014). Methodology to assess clinical liver safety data. Drug Safety, 37 Suppl:33-45.

This list was generated on Sun May 26 19:19:53 2019 CEST.